NDC 51167-746 - Trikafta
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51167-746
- Package NDCs from labels
- 51167-746-07
- Manufacturer
- Vertex Pharmaceuticals Incorporated | AndersonBrecon Inc. | Shanghai SynTheAll Pharmaceutical, Co., Ltd. | F.I.S. Fabbrica Italiana Sintetici S.P.A. | Pharmaceutical Manufacturing Research Services, Inc. | Almac Pharma Services LLC
- Effective date
- 2026-06-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Trikafta | Vertex Pharmaceuticals Incorporated | AndersonBrecon Inc. | Shanghai SynTheAll Pharmaceutical, Co., Ltd. | F.I.S. Fabbrica Italiana Sintetici S.P.A. | Pharmaceutical Manufacturing Research Services, Inc. | Almac Pharma Services LLC | 2026-06-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51167-746-07 | Trikafta | 1 in 1 PACKET | GRANULE | 7 | 75 mg | 22 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Renewal Firming Day Broad Spectrum SPF 30 | TITANIUM DIOXIDE, ZINC OXIDE | BURT'S BEES, INC. | 18ceb5d8-4b76-6a54-e054-00144ff88e88 | 2015-06-18 | Warnings | 15FIX9V2JP |
| TiZO2 | TITANIUM DIOXIDE, ZINC OXIDE | Fallien Cosmeceuticals, LTD. | 30468afc-9616-4765-b046-12e97a0a7827 | 2010-12-20 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.